Sugi Predict

Sugi Predict / Compounds / SCHEMBL854444

SCHEMBL854444

SCHEMBL854444

Cc1ccc(C#N)c2ccccc12

nearest known ligand 0.59

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 2/20 0.59
▸ IMPDH2 P12268 3/20 0.57
▸ IMPDH1 P20839 2/20 0.57
▸ TSHR P16473 1/20 0.54
▸ AR P10275 8/20 0.47
▸ CYP2A6 P11509 1/20 0.46
▸ ALDH1A1 P00352 2/20 0.44
▸ KDM4E B2RXH2 1/20 0.44
▸ GAA P10253 1/20 0.44
▸ MAPT P10636 1/20 0.44
▸ NSD2 O96028 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL8726070 0.98 CYP1A2 (0.56) CYP1A2IMPDH2IMPDH1TSHRAR
SCHEMBL879078 0.86 TSHR (0.60) CYP1A2IMPDH2IMPDH1TSHRAR
SCHEMBL151936 0.85 IMPDH2 (0.64) IMPDH2IMPDH1TSHRARALDH1A1
SCHEMBL29489135 0.85 IMPDH2 (0.64) IMPDH2IMPDH1TSHRARALDH1A1
SCHEMBL11193357 0.83 IMPDH2 (0.61) IMPDH2IMPDH1TSHRARALDH1A1
SCHEMBL11228244 0.80 IMPDH2 (0.59) IMPDH2IMPDH1TSHRARALDH1A1
SCHEMBL23625536 0.79 TSHR (0.52) CYP1A2IMPDH2IMPDH1TSHRAR
SCHEMBL11423777 0.79 TSHR (0.47) CYP1A2IMPDH2IMPDH1TSHRAR
SCHEMBL16917824 0.78 IMPDH2 (0.57) IMPDH2IMPDH1ARALDH1A1KDM4E
SCHEMBL2203417 0.77 CYP1A2 (0.59) CYP1A2IMPDH2IMPDH1TSHRCYP2A6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 265 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114908342-B Tin precipitation liquid medicine and circuit board tin precipitation method 深圳市板明科技股份有限公司 2022-11-08 — — CN claimed
CN-114908342-A Tin precipitation liquid medicine and circuit board tin precipitation method 深圳市板明科技股份有限公司 2022-08-16 — — CN claimed
US-20250000854-A1 4-(Aminomethyl)-6-(1-Methyl-1H-Pyrazol-4-YL)Isoquinolin-1(2H)-One Derivatives as MTA-Cooperative Inhibitors of PRMT5 BEIGENE, LTD. (KY) 2025-01-02 — — US disclosed
US-20240208954-A1 OXADIAZOLE COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION AND USE THEREOF SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES (CN) 2024-06-27 — — US disclosed
WO-2023174250-A1 4- (AMINOMETHYL) -6- (1-METHYL-1H-PYRAZOL-4-YL) ISOQUINOLIN-1 (2H) -ONE DERIVATIVES AS MTA-COOPERATIVE INHIBITORS OF PRMT5 BEIGENE , LTD. (KY) 2023-09-21 — — WO disclosed
EP-4177255-A1 OXADIAZOLE COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION AND USE THEREOF Shanghai Institute of Materia Medica, Chinese Academy of Sciences (CN) 2023-05-10 — — EP disclosed
EP-4177255-A1 OXADIAZOLE COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION AND USE THEREOF Shanghai Institute of Materia Medica, Chinese Academy of Sciences (CN) 2023-05-10 — — EP disclosed
WO-2023000834-A1 BENZIMIDAZOLE OR AZABENZIMIDAZOLE-6-CARBOXYLIC ACID COMPOUND AND USE THEREOF 广州必贝特医药股份有限公司 2023-01-26 — — WO disclosed
CN-115515956-A Benzimidazole derivative and preparation method and medical application thereof 深圳信立泰药业股份有限公司 2022-12-23 — — CN disclosed
CN-114908342-B Tin precipitation liquid medicine and circuit board tin precipitation method 深圳市板明科技股份有限公司 2022-11-08 — — CN disclosed
CN-114908342-A Tin precipitation liquid medicine and circuit board tin precipitation method 深圳市板明科技股份有限公司 2022-08-16 — — CN disclosed
WO-2002098880-A1 5-ETHYL-IMIDAZOTRIAZINONES BAYER HEALTHCARE AG (DE) 2002-12-12 — — WO disclosed
US-20020169200-A1 Substituted indoles and their use as integrin antagonists 3-DIMENSIONAL PHARMACEUTICALS, INC. 2002-11-14 — — US disclosed
WO-2002060438-A1 SUBSTITUTED INDOLES AND THEIR USE AS INTEGRIN ANTAGONISTS 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 2002-08-08 — — WO disclosed
US-5935976-A Antiviral ethers of aspartate protease substrate isosteres NOVARTIS CORPORATION (US) 1999-08-10 — — US disclosed
US-5807891-A RETROVIRUSES NOVARTIS AG (CH) 1998-09-15 — — US disclosed
US-5663200-A CARBAMOYL PEPTIDE DERIVATIVES AS VIRICIDES CIBA-GEIGY CORPORATION (US) 1997-09-02 — — US disclosed
EP-0708085-A2 Antiviral ethers of aspartate protease substrate isosteres CIBA-GEIGY AG (CH) 1996-04-24 — — EP disclosed
US-4016195-A OPTICAL BRIGHTENERS HOECHST AKTIENGESELLSCHAFT (DT) 1977-04-05 — — US disclosed
US-3957846-A OPTICAL BRIGHTENERS, LACQUERS, SYNTHETIC FIBERS HOECHST AKTIENGESELLSCHAFT (DT) 1976-05-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020169200-A1 Substituted indoles and their use as integrin antagonists ITGAV, ITGAL, ITGA5 CYP1A2 3322/4885IMPDH2 3429/4885IMPDH1 2926/4885
US-20240208954-A1 OXADIAZOLE COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION AND USE THEREOF SUCNR1, GPR35, P2RY11 CYP1A2 1201/4885IMPDH2 561/4885IMPDH1 245/4885
US-20250000854-A1 4-(Aminomethyl)-6-(1-Methyl-1H-Pyrazol-4-YL)Isoquinolin-1(2H)-One Derivatives as MTA-Cooperative Inhibitors of PRMT5 PRMT5, PRMT1, PRMT6 CYP1A2 4456/4885IMPDH2 417/4885IMPDH1 278/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.